Javier Cortés Castán
EIOC/LinkedIn

“Targeting the AKT Pathway” by Javier Cortés Castán on Day 2 of EIOC 2025

EIOC (Excellence in Oncology Care) shared a post on LinkedIn:

“Join us on Day 2 of EIOC 2025 (1st November) for the Breast Cancer Symposium, featuring Dr. Javier Cortés Castán from the IBCC – International Breast Cancer Center, Spain.

He will present ‘Targeting the AKT Pathway: Redefining Outcomes in HR+/HER2− Metastatic Breast Cancer (mBC),’ highlighting how AKT inhibition is reshaping treatment strategies and improving patient outcomes.

  • Date: 1st November 2025
  • Venue: InterContinental Dubai Festival City

Register now.”

More posts featuring EIOC.